Open AccessAcyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability
Author(s) -
Anupam Das,
Abheek Sil,
Nilay Kanti Das,
Kaushik Roy,
Anjan Das,
Debabrata Bandyopadhyay
Publication year - 2015
Publication title -
indian dermatology online journal
Language(s) - English
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/2229-5178.156389
Subject(s) - medicine , pityriasis rosea , tolerability , adverse effect , randomized controlled trial , group b , double blind , clinical trial , dermatology , surgery , placebo , pathology , alternative medicine
Pityriasis rosea (PR) is an acute inflammatory dermatosis. The association of human herpes virus 6 and 7 suggests the utility of use of antiviral agents in this disease.